[144] Acuity Inc. SEC Filing

Rhea-AI Filing Summary

On June 26, 2025, Quanterix Corporation (QTRX) filed an 8-K to announce logistics for its 2025 Annual Meeting of Stockholders. The meeting will be held virtually on September 23, 2025 at 9:00 a.m. ET. Because the meeting date falls more than 30 days after the 2024 meeting anniversary, the company has reset key shareholder deadlines:

• Rule 14a-8 proposals must be received by the corporate secretary by July 11, 2025.
• Bylaw-based business or director nominations (outside Rule 14a-8) also require written notice by July 11, 2025.
• Universal proxy notification (Rule 14a-19) is due by July 25, 2025.

No financial results, strategic transactions or operational updates were disclosed. The filing is procedural, ensuring compliance with SEC rules and providing investors sufficient time to submit proposals or nominations.

Insights

Corporate Governance Expert

TL;DR: Date shift resets proxy & nomination deadlines; procedural, not value-changing.

The 8-K is purely administrative. By moving the annual meeting to September 23, Quanterix triggers new SEC and bylaw deadlines. The company explicitly sets July 11 for Rule 14a-8 and bylaw notices, and July 25 for universal proxy compliance. This timely notice mitigates any potential governance disputes and aligns with best-practice transparency but has no direct financial impact. Investors who plan activism must act within the shortened window; otherwise, status quo prevails.

Securities Analyst

TL;DR: Neutral 8-K; no earnings or strategic data, minimal trading impact.

From a market perspective, the disclosure neither alters cash flow expectations nor changes risk profile. It simply informs of scheduling and procedural deadline changes. Liquidity, guidance and competitive outlook remain untouched. Trading volumes are unlikely to react materially; governance-focused investors may note the earlier deadlines, but fundamental valuation for QTRX should remain unchanged.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE STE 1000 Atlanta GA 30326	4125	1230507.22	30644832	07/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/25/2023	Vesting of a Stock Award	ACUITY INC. (DE)			92	10/25/2023	Compensatory Payment
Common	10/26/2023	Vesting of a Stock Award	ACUITY INC. (DE)			387	10/26/2023	Compensatory Payment
Common	10/24/2024	Vesting of Stock Awards	ACUITY INC. (DE)			1109	10/24/2024	Compensatory Payment
Common	10/25/2024	Vesting of a Stock Award	ACUITY INC. (DE)			212	10/25/2024	Compensatory Payment
Common	07/01/2025	Exercise of a Stock Award	ACUITY INC. (DE)			2325	07/01/2025	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

When will Quanterix (QTRX) hold its 2025 Annual Meeting?

September 23, 2025 at 9:00 a.m. ET, conducted virtually.

What is the new deadline for Rule 14a-8 shareholder proposals to Quanterix?

Proposals must reach the corporate secretary by July 11, 2025.

By when must Quanterix investors submit director nominations outside Rule 14a-8?

Written notice, with all bylaw-required information, is also due by July 11, 2025.

What is the deadline for universal proxy (Rule 14a-19) notifications for QTRX?

Stockholders intending to solicit alternate director proxies must notify the company by July 25, 2025.

Does the 8-K include any financial or earnings information for Quanterix?

No. The filing is limited to meeting logistics and shareholder deadline revisions.